Literature DB >> 2193939

The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer.

E Loumaye1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2193939     DOI： 10.1093/oxfordjournals.humrep.a137105

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  16 in total

1.  Preretrieval predictors of pregnancy in IVF.

Authors:  A J Duleba; N Hausman; E E Jones; D L Olive
Journal:  J Assist Reprod Genet       Date:  1997-04       Impact factor: 3.412

2.  In vitro fertilization programmed for weekday-only oocyte harvest: analysis of outcome based on actual retrieval day.

Authors:  A Ben-Chetrit; S Senoz; E M Greenblatt
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

3.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

4.  Human chorionic gonadotropin-to-oocyte collection interval in a superovulation IVF program. A prospective study.

Authors:  G Nargund; F Reid; J Parsons
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

5.  Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages.

Authors:  R Felberbaum; T Reissmann; W Küpker; S Al-Hasani; O Bauer; T Schill; C Zoll; C Diedrich; K Diedrich
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

Review 6.  Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?

Authors:  Georg Griesinger; Ricardo E Felberbaum; Askan Schultze-Mosgau; Klaus Diedrich
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.

Authors:  Ernesto Bosch; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

8.  GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran.

Authors:  Ensieh Tehraninejad; Akram Ghahghaei Nezamabadi; Batool Rashidi; Maryam Sohrabi; Maryam Bagheri; Fedyeh Haghollahi; Elham Azimi Nekoo; Mina Jafarabadi
Journal:  Iran J Reprod Med       Date:  2011

9.  Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.

Authors:  Bernd Th Krause; Ralf Ohlinger; Annette Haase
Journal:  Biologics       Date:  2009-07-13

10.  Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles.

Authors:  Kang Woo Cheon; Sang Jin Song; Bum Chae Choi; Seung Chul Lee; Hong Bok Lee; Seung Youn Yu; Keun Jai Yoo
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.